RenalytixAI to Participate in the Stifel 2020 Healthcare Conference
13 nov. 2020 02h00 HE
|
Renalytix AI plc.
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of...
Renalytix AI plc (“RenalytixAI” or the “Company”) Change of adviser
06 nov. 2020 07h00 HE
|
Renalytix AI plc.
NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of...
Posting of Annual Report & Accounts and Notice of AGM
02 nov. 2020 10h30 HE
|
Renalytix AI plc.
NEW YORK, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of...
Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report
27 oct. 2020 03h00 HE
|
Renalytix AI plc.
NEW YORK, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of...
RenalytixAI Receives California Commercial Laboratory Certification
22 sept. 2020 07h00 HE
|
Renalytix AI plc.
NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Renalytix AI, Inc. (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management...
RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System
18 sept. 2020 07h00 HE
|
Renalytix AI plc.
NEW YORK, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management...
RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX
26 août 2020 07h00 HE
|
Renalytix AI plc.
NEW YORK, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of...
RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease
21 août 2020 03h00 HE
|
Renalytix AI plc.
NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced a collaboration with AstraZeneca (LSE/STO/NYSE: AZN) to develop and launch precision...
KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients
03 août 2020 08h00 HE
|
Renalytix AI plc.
Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19 Mount Sinai-Led Study to Assess 4,000 Surviving COVID-19 Patients NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Mount Sinai...
RenalytixAI Announces Over Allotment Option Exercise Raises an Additional US$10.9M
27 juil. 2020 08h00 HE
|
Renalytix AI plc.
NEW YORK, July 27, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“RenalytixAI” or the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on...